Cargando…
MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating autophagy
BACKGROUND: Cisplatin (CDDP) is of importance in cancer treatment and widely used in advanced gastric cancer (GC). However, its clinical usage is limited due to its resistance, and the regulatory mechanism of CDDP resistance in GC has not yet been fully elucidated. In this study, we first conducted...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
PeerJ Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257393/ https://www.ncbi.nlm.nih.gov/pubmed/37304872 http://dx.doi.org/10.7717/peerj.15441 |